CYTORI THERAPEUTICS INC - COM NEW (CYTX)

CUSIP: 23283K204

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM NEW
Total 13F shares
4,443,046
Share change
+744,006
Total reported value
$1,272,038
Price per share
$0.29
Number of holders
22
Value change
+$209,719
Number of buys
10
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 23283K204?
CUSIP 23283K204 identifies CYTX - CYTORI THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYTORI THERAPEUTICS INC - COM NEW (CYTX) as of Q1 2018

As of 31 Mar 2018, CYTORI THERAPEUTICS INC - COM NEW (CYTX) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,443,046 shares. The largest 10 holders included PERKINS CAPITAL MANAGEMENT INC, Jefferies Group LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, Creative Planning, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, and Bank of New York Mellon Corp. This page lists 22 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.